Don’t get lost in translation: How smart design and technology are enabling bench-to-bedside in translational research
Abstract only In recent years, cell-based therapies such as immunotherapy have shown very interesting and promising results, most notably in the fields of oncology and tissue regeneration. As researchers in these and other related fields continue to solve increasingly difficult scientific problems,...
Gespeichert in:
Veröffentlicht in: | Science (American Association for the Advancement of Science) 2015-10, Vol.350 (6257), p.223-223 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Abstract only
In recent years, cell-based therapies such as immunotherapy have shown very interesting and promising results, most notably in the fields of oncology and tissue regeneration. As researchers in these and other related fields continue to solve increasingly difficult scientific problems, they need to prepare for the next step: moving their treatment out of the research lab and into a larger-scale manufacturing environment. This step presents an entirely new set of critical challenges, including workflow management, resource planning, and ensuring the most efficient use of precious patient samples. In this webinar you'll hear from leading professionals who are experienced in both scaling-up (generating more cells per batch) and scaling-out (generating more batches) the production of their “living drugs” in the most effective way possible. The reliability of this process has real-world impacts on patient well-being and survival.
View the Webinar |
---|---|
ISSN: | 0036-8075 1095-9203 |
DOI: | 10.1126/science.350.6257.223-c |